Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$154.28 1.61 (1.05%) as of 4:30 Thu 5/16


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 405.76(B)
Last Volume: 7,590,777 Avg Vol: 8,301,717
52 Week Range: $144.45 - $174.48
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  21
Guru Rank Value     : 20.3
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 8,891 68,288 115,451 522,170
Total Sell Value $1,441,765 $10,723,734 $18,652,688 $88,845,171
Total People Sold 1 2 5 10
Total Sell Transactions 1 2 5 24
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 1526
  Page 12 of 62  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sneed Michael E EVP, Global Corp Aff & COO   •       •      –    2020-12-09 4 OE $62.20 $3,399,976 D/D 54,662 110,741     -
   Gorsky Alex Chairman, CEO   •       •      –    2020-11-25 4 GD $0.00 $0 D/D 20,950 432,820     -
   Gorsky Alex Chairman, CEO   •       •      –    2020-09-14 4 A $0.00 $0 D/D 2,750 453,751     -
   Wengel Kathryn E EVP, Chief GSC Officer   •       •      –    2020-09-02 4 S $153.51 $2,473,938 D/D (16,115) 58,420 -4%     
   Wengel Kathryn E EVP, Chief GSC Officer   •       •      –    2020-09-02 4 OE $62.20 $1,027,323 D/D 16,115 74,535     -
   Mcevoy Ashley EVP, WW Chair, Medical Devices   •       •      –    2020-07-28 4 S $147.47 $4,276,630 D/D (29,000) 21,682 -3%     
   Perez William D Director   •       •      –    2020-03-13 4 B $127.69 $63,843 D/D 500 16,030 2.39 11%     
   Mongon Thibaut Exec VP, WW Chair, Consumer   •       •      –    2020-02-21 4 S $147.96 $5,803,583 D/D (39,224) 35,815 6%     
   Mongon Thibaut Exec VP, WW Chair, Consumer   •       •      –    2020-02-21 4 OE $90.44 $1,738,619 D/D 19,224 75,039     -
   Duato Joaquin Vice Chair, Exec Committee   •       •      –    2020-02-13 4 D $150.46 $6,605,796 D/D (43,904) 176,469     -
   Duato Joaquin Vice Chair, Exec Committee   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 105,668 220,373     -
   Stoffels Paulus Vice Chair, Exec Committee   •       •      –    2020-02-13 4 D $150.46 $2,422,556 D/D (16,101) 254,799     -
   Stoffels Paulus Vice Chair, Exec Committee   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 39,381 270,900     -
   Taubert Jennifer L EVP, WW Chair, Pharmaceuticals   •       •      –    2020-02-13 4 D $150.46 $1,237,985 D/D (8,228) 107,585     -
   Taubert Jennifer L EVP, WW Chair, Pharmaceuticals   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 16,084 115,813     -
   Wengel Kathryn E EVP, Chief GSC Officer   •       •      –    2020-02-13 4 D $150.46 $1,070,072 D/D (7,112) 58,420     -
   Wengel Kathryn E EVP, Chief GSC Officer   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 15,809 65,532     -
   Mcevoy Ashley EVP, WW Chair, Medical Devices   •       •      –    2020-02-13 4 D $150.46 $877,483 D/D (5,832) 50,664     -
   Mcevoy Ashley EVP, WW Chair, Medical Devices   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 13,747 56,496     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2020-02-13 4 D $150.46 $1,416,280 D/D (9,413) 143,284     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 20,326 152,697     -
   Decker Robert J Controller, CAO   •       •      –    2020-02-13 4 D $150.46 $83,505 D/D (555) 13,391     -
   Decker Robert J Controller, CAO   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 1,499 13,946     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2020-02-13 4 D $150.46 $1,563,731 D/D (10,393) 100,166     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2020-02-13 4 OE $0.00 $0 D/D 22,231 110,559     -

  1526 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 62
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed